Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Foghorn Therapeutics Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
4
| Agresta Samuel (Chief Medical Officer) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Sold 311,297 shares
@ $8.25, valued at
$2.6M
Exercised 311,297 options to buy
@ $3.72, valued at
$1.2M
|
|
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2023 |
4
| GOTTSCHALK ADRIAN (CEO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Gifted 300,000 shares
@ $0 |
|
| 02/22/2023 |
4
| GOTTSCHALK ADRIAN (CEO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Gifted 123,479 shares
@ $0
Gifted 123,479 shares
@ $0
Acquired 4,371 shares
@ $0
Disposed of 4,371 shares
@ $0
Gifted 4,371 shares
@ $0
Gifted 4,371 shares
@ $0
Disposed of 184,939 shares
@ $0
Acquired 184,939 shares
@ $0 |
|
| 01/30/2023 |
4
| Agresta Samuel (Chief Medical Officer) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 60,000 options to buy
@ $8.38, valued at
$502.8k
|
|
| 01/30/2023 |
4
| Cavalie Fanny (Chief Strategy/Bus Ops Officer) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 65,000 options to buy
@ $8.38, valued at
$544.7k
|
|
| 01/30/2023 |
4
| Bellon Steven F. (Chief Scientific Officer) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 100,000 options to buy
@ $8.38, valued at
$838k
|
|
| 01/30/2023 |
4
| Costa Carlos (Chief People Officer) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 65,000 options to buy
@ $8.38, valued at
$544.7k
|
|
| 01/30/2023 |
4
| LaCascia Michael (Chief Legal Officer) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 90,000 options to buy
@ $8.38, valued at
$754.2k
|
|
| 01/30/2023 |
4
| GOTTSCHALK ADRIAN (CEO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 280,000 options to buy
@ $8.38, valued at
$2.3M
|
|
| 01/30/2023 |
4
| Reine Allan (CFO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 90,000 options to buy
@ $8.38, valued at
$754.2k
|
|
| 09/19/2022 |
4
| GOTTSCHALK ADRIAN (CEO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Exercised 40,000 options to buy
@ $0.54, valued at
$21.6k
|
|
| 09/14/2022 |
4
| GILL SIMBA (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Gifted 47,939 shares
@ $0
Exercised 82,000 options to buy
@ $0.73, valued at
$59.9k
|
|
| 09/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Bellon Steven F. (Chief Scientific Officer) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Exercised 1,858 options to buy
@ $3.72, valued at
$6.9k
|
|
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Bellon Steven F. (Chief Scientific Officer) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Exercised 675 options to buy
@ $0.73, valued at
$492.8
Exercised 3,717 options to buy
@ $3.72, valued at
$13.8k
|
|
| 01/28/2022 |
4
| Agresta Samuel (Chief Medical Officer) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 125,000 options to buy
@ $14.87, valued at
$1.9M
|
|
| 01/28/2022 |
4
| Bellon Steven F. (Chief Scientific Officer) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 150,000 options to buy
@ $14.87, valued at
$2.2M
|
|
| 01/28/2022 |
4
| LaCascia Michael (Chief Legal Officer) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 135,000 options to buy
@ $14.87, valued at
$2M
|
|
| 01/28/2022 |
4
| Reine Allan (CFO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 135,000 options to buy
@ $14.87, valued at
$2M
|
|
| 01/28/2022 |
4
| GOTTSCHALK ADRIAN (CEO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 440,000 options to buy
@ $14.87, valued at
$6.5M
|
|
| 12/16/2021 |
4
| KADOCH CIGALL (10% Owner) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Gifted 333,333 shares
@ $0 |
|
| 12/13/2021 |
4
| DECICCO CARL (Chief Scientific Officer) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Exercised 76,892 options to buy
@ $3.72, valued at
$286k
Exercised 27,418 options to buy
@ $3.72, valued at
$102k
|
|
| 08/23/2021 |
4
| GOTTSCHALK ADRIAN (CEO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Exercised 23,000 options to buy
@ $0.54, valued at
$12.4k
|
|
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|